Clinical Trials Browser

Phase 3 × Completed × olokizumab × Clear all

NCT03120949 2023-10-12

CREDO 4

Phase 3 Completed

2,106 enrolled 30 charts

Arthritis, Rheumatoid, Lymphoma, Follicular

NCT02760433 2023-09-21

CREDO 3

Phase 3 Completed

368 enrolled 21 charts

Arthritis, Rheumatoid